Evidence/Findings:
<p>Based on record review, observation, and interview, the manager failed to ensure that a resident's medical record contained a medication order from a medical practitioner for each medication that was administered to the resident, for one of two residents sampled. The deficient practice posed a risk as medication administered could not be verified against a medication order.</p><p><br></p><p>Findings include: </p><p><br></p><p>1. A review of R2's medical record revealed R2 received medication administration. </p><p><br></p><p>2. A review of R2's medical record revealed a medication list for the following medications:</p><ul><li>Alprazolam 0.5 milligrams (mg), 1 tablet by mouth (po) twice a day (bid);</li><li>Acetaminophen 325 mg, 2 tablets po bid;</li><li>Trazodone HCl 100 mg, 1 tablet po at bedtime (qhs);</li><li>Tramadol HCl 50 mg, 1 tablet po bid;</li><li>Aspirin 81 mg, 1 tablet po daily (qd);</li><li>Sennosides 8.6 mg, 1 tablet po bid;</li><li>Carvedilol 12.5 mg, 2 tablets po bid;</li><li>Amlodipine Besylate 5 mg, 2 tablets po qd; and</li><li>Clopidogrel Bisulfate 75 mg, 1 tablet po qd.</li></ul><p>However, the medication list was not signed by a medical practitioner as required.</p><p><br></p><p>3. A review of R2's medication administration record (MAR) for July 2025 revealed R2 was administered the following medications;</p><ul><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Alprazolam 0.5 mg,</span> 1 tablet po bid, and indicated 1 tablet was administered at 8:00 AM and 8:00 PM July 1, 2025- present;</li><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Acetaminophen 325 mg, 2 tablets po bid,</span> and indicated 2 tablets were administered at 8:00 AM and 8:00 PM July 1, 2025- present;</li><li>Trazodone HCl 100 mg, 1 tablet po qhs, <span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">and indicated 1 tablet was administered at 8:00 PM July 1, 2025- present;</span></li><li>Tramadol HCl 50 mg, 1 tablet po bid<span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">, and indicated 1 tablet was administered at 8:00 AM and 8:00 PM July 1, 2025- present;</span></li><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Aspirin 81 mg, 1 tablet po qd, and indicated 1 tablet was administered at 8:00 AM July 1, 2025- present;</span></li><li>Sennosides 8.6 mg, 1 tablet po bid, <span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">and indicated 1 tablet was administered at 8:00 AM and 8:00 PM July 1, 2025- present;</span></li><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Carvedilol 12.5 mg, 2 tablets po bid, and indicated 2 tablets were administered at 8:00 AM and 8:00 PM July 1, 2025- present;</span></li><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Amlodipine Besylate 5 mg, 2 tablets po qd, and indicated 2 tablets were administered at 8:00 AM July 1, 2025- present; and</span></li><li><span style="color: rgb(68, 68, 68); background-color: rgb(255, 255, 255);">Clopidogrel Bisulfate 75 mg, 1 tablet po qd, and indicated 1 tablet was administered at 8:00 AM July 1, 2025- present.</span></li></ul><p><br></p><p>4. In an exit interview, the finding was reviewed with E1 and no additional information was provided.</p>
Summary:
The following deficiencies were found during the on-site compliance inspection and investigation of complaint 00135537 conducted on July 17, 2025: